J.P. Deslys

766 total citations
17 papers, 548 citations indexed

About

J.P. Deslys is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, J.P. Deslys has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Neurology and 4 papers in Neurology. Recurrent topics in J.P. Deslys's work include Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (8 papers) and Alcoholism and Thiamine Deficiency (3 papers). J.P. Deslys is often cited by papers focused on Prion Diseases and Protein Misfolding (15 papers), Neurological diseases and metabolism (8 papers) and Alcoholism and Thiamine Deficiency (3 papers). J.P. Deslys collaborates with scholars based in France, Germany and United Kingdom. J.P. Deslys's co-authors include Dominique Dormont, Emmanuel Comoy, A Alpérovitch, J J Hauw, Thierry Billette de Villemeur, J.-P. Brandel, J L Chaussain, Yves Agid, V. Sazdovitch and Jean-Louis Kémény and has published in prestigious journals such as Nature, Neurology and Scientific Reports.

In The Last Decade

J.P. Deslys

17 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Deslys France 12 485 260 105 78 48 17 548
Ignazio Calì United States 19 1.1k 2.3× 549 2.1× 371 3.5× 131 1.7× 142 3.0× 40 1.2k
Maxime Bélondrade France 12 262 0.5× 94 0.4× 44 0.4× 34 0.4× 48 1.0× 14 315
Hugh Fraser United Kingdom 7 539 1.1× 249 1.0× 201 1.9× 40 0.5× 66 1.4× 8 586
R. J. Kascsak United States 4 487 1.0× 260 1.0× 208 2.0× 25 0.3× 45 0.9× 6 537
Sven Forner United States 8 308 0.6× 154 0.6× 73 0.7× 96 1.2× 41 0.9× 9 365
Maryellen C. Franko United States 9 291 0.6× 124 0.5× 101 1.0× 48 0.6× 22 0.5× 11 377
Daniela Saverioni Italy 8 433 0.9× 227 0.9× 95 0.9× 89 1.1× 68 1.4× 9 456
Irit Kahana Israel 9 453 0.9× 272 1.0× 164 1.6× 47 0.6× 32 0.7× 9 494
N. Tomokane Japan 5 538 1.1× 188 0.7× 81 0.8× 83 1.1× 93 1.9× 5 593
Aurélie Alleaume‐Butaux France 8 158 0.3× 73 0.3× 39 0.4× 18 0.2× 71 1.5× 10 245

Countries citing papers authored by J.P. Deslys

Since Specialization
Citations

This map shows the geographic impact of J.P. Deslys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Deslys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Deslys more than expected).

Fields of papers citing papers by J.P. Deslys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Deslys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Deslys. The network helps show where J.P. Deslys may publish in the future.

Co-authorship network of co-authors of J.P. Deslys

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Deslys. A scholar is included among the top collaborators of J.P. Deslys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Deslys. J.P. Deslys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Roux, G. Le, Rafika Jarray, Anne-Cécile Guyot, et al.. (2019). Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model. Scientific Reports. 9(1). 16310–16310. 44 indexed citations
2.
Lacroux, Caroline, Emmanuel Comoy, Mohammed Moudjou, et al.. (2014). Preclinical Detection of Variant CJD and BSE Prions in Blood. PLoS Pathogens. 10(6). e1004202–e1004202. 85 indexed citations
3.
Comoy, Emmanuel, Jacqueline Mikol, Valérie Durand, et al.. (2013). Induction d’une maladie neurologique transmissible sans accumulation de protéine du prion chez des primates inoculés avec des dérivés sanguins contaminés : un nouveau risque transfusionnel lié aux prions ?. Transfusion Clinique et Biologique. 20(3). 267–267. 1 indexed citations
4.
Deslys, J.P.. (2003). Prions et risques pour la transfusion sanguine : le point en 2003. Transfusion Clinique et Biologique. 10(3). 113–125. 2 indexed citations
5.
Deslys, J.P., Emmanuel Comoy, S. A. C. Hawkins, et al.. (2001). Screening slaughtered cattle for BSE. Nature. 409(6819). 476–478. 58 indexed citations
6.
Créminon, Christophe, Yveline Frobert, Philippe Frétier, et al.. (2000). Specific determination of the proteinase K-resistant form of the prion protein using two-site immunometric assays. Application to the post-mortem diagnosis of BSE. PubMed. 197–205. 31 indexed citations
7.
Hauw, J.‐J., V. Sazdovitch, Jean Laplanche, et al.. (2000). Neuropathologic variants of sporadic Creutzfeldt–Jakob disease and codon 129 of PrP gene. Neurology. 54(8). 1641–1646. 53 indexed citations
8.
Haı̈k, Stéphane, Jean‐Michel Peyrin, Laurence Lins, et al.. (2000). Neurotoxicity of the Putative Transmembrane Domain of the Prion Protein. Neurobiology of Disease. 7(6). 644–656. 40 indexed citations
9.
Haı̈k, Stéphane, J.P. Brandel, V. Sazdovitch, et al.. (2000). Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt–Jakob disease. Neurology. 55(9). 1401–1404. 49 indexed citations
10.
Jordan, David R., Catherine Souchier, C. Mottolèse, et al.. (2000). The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathologica. 99(6). 704–708. 8 indexed citations
11.
d’Aignaux, Jérôme Huillard, Dominique Costagliola, Jean Maccario, et al.. (1999). Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France. Neurology. 53(6). 1197–1197. 62 indexed citations
12.
Grigoriev, V. B., F Escaig-Haye, Corinne Ida Lasmézas, et al.. (1999). Ultrastructural localization of cellular prion protein (PrPc) at the neuromuscular junction. Journal of Neuroscience Research. 55(2). 261–267. 2 indexed citations
13.
Villemeur, T Billette de, J.P. Deslys, A Alpérovitch, et al.. (1996). Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 47(3). 690–695. 52 indexed citations
14.
Villemeur, Thierry Billette de, A. Gélot, J.P. Deslys, et al.. (1994). Iatrogenic Creutzfeldt—Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathology and Applied Neurobiology. 20(2). 111–117. 34 indexed citations
15.
Masson, Catherine, J.P. Deslys, Dominique Hénin, et al.. (1994). Creutzfeldt‐Jakob disease after pituitary‐derived human growth hormone therapy. Neurology. 44(1). 179–179. 12 indexed citations
16.
Deslys, J.P., et al.. (1994). Maladie de Creutzfeldt-Jakob iatrogène et transfusion sanguine. médecine/sciences. 10(6-7). 734–734. 1 indexed citations
17.
Villemeur, T Billette de, et al.. (1992). [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].. PubMed. 148(5). 328–34. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026